Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
Authors
Keywords
Soft tissue sarcoma, Cancer stem cells, Tyrosine kinase inhibitors, Sorafenib, Pazopanib, Regorafenib, ALDH
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-10
DOI
10.1186/1471-2407-14-756
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients with Locally Advanced Soft Tissue Sarcoma of the Extremity
- (2014) Robert J. Canter et al. ANNALS OF SURGICAL ONCOLOGY
- Pazopanib: A Review of Its Use in the Management of Advanced Renal Cell Carcinoma
- (2014) Paul L. McCormack DRUGS
- Sorafenib/Regorafenib and Lapatinib Interact to kill CNS Tumor Cells
- (2014) Hossein A. Hamed et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
- (2013) C. Le Magnen et al. CLINICAL CANCER RESEARCH
- Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: A new treatment for metastatic soft tissue sarcoma
- (2013) Girolamo Ranieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer Stem Cells in Pediatric Sarcomas
- (2013) Filemon S. Dela Cruz Frontiers in Oncology
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract
- (2012) Hiroshi Kitamura et al. MODERN PATHOLOGY
- Defining the mode of tumour growth by clonal analysis
- (2012) Gregory Driessens et al. NATURE
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
- (2012) A. G. Schepers et al. SCIENCE
- Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
- (2011) Margaret von Mehren et al. CANCER
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
- (2011) Olga A. Guryanova et al. CANCER CELL
- CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers
- (2011) Junwei Chen et al. GENES CHROMOSOMES & CANCER
- CD133 expression in chemo-resistant Ewing sarcoma cells
- (2010) Xiaohua Jiang et al. BMC CANCER
- High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
- (2010) Christel van den Hoogen et al. CANCER RESEARCH
- Tumor-Initiating Cells Are Rare in Many Human Tumors
- (2010) Kota Ishizawa et al. Cell Stem Cell
- Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity
- (2010) Lin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance
- (2010) Honoki ONCOLOGY REPORTS
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
- (2010) Ola Awad et al. PLoS One
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now